SKN | Standard Nuclear Targets Public Markets as IPO Highlights Rising Investor Focus on Nuclear Energy Supply Chain
Standard Nuclear, Inc. is preparing for its anticipated IPO, seeking to raise fresh capital as investor interest in the nuclear energy sector continues to...
SKN | VogenX Files for U.S. IPO to Advance Phase 2 Metabolic Disease Pipeline
VogenX has filed for a U.S. initial public offering, seeking to raise an estimated $25 million to support the continued development of its pipeline...
SKN | Tarsier Pharma Increases IPO Size by 11% Ahead of $50 Million NYSE Listing
Tarsier Pharma has increased the size of its upcoming initial public offering (IPO), signaling stronger fundraising ambitions as it prepares to enter the U.S....
SKN | Braveheart Bio Files for $100 Million IPO to Advance Phase 3 Cardiovascular Drug Development
Braveheart Bio has filed for an initial public offering (IPO) seeking to raise up to $100 million as it prepares to advance its lead...
SKN | KraneShares Trust Eyes Market Debut as New ETF Offering Expands Investor Access to Thematic Strategies
KraneShares Trust is preparing to launch a new exchange-traded fund (ETF), adding to its growing lineup of thematic and globally focused investment products. The...